Tirzepatide
A product with established research around appetite, blood-sugar regulation and weight-related outcomes.
Everything currently available and everything coming next, all in one place. Browse the full collection or filter by what you’re looking for.
A product with established research around appetite, blood-sugar regulation and weight-related outcomes.
A copper-binding peptide widely researched in relation to skin and tissue biology.
A small peptide fragment studied primarily for its role in inflammatory signaling, particularly in preclinical research.
An investigational compound currently being studied for metabolic and weight-related outcomes.
A growth-hormone-releasing factor analogue with a specific approved medical use in HIV-associated lipodystrophy.
A mitochondria-derived peptide being investigated for its role in cellular energy metabolism, metabolic signaling and stress response.
A combination-format wellness product pairing a lipotropic-style formulation with vitamin B12.
A three-component blend of GHK-Cu, BPC-157 and TB-500, bringing together research areas involving skin biology, tissue repair and recovery.
A four-component blend of GHK-Cu, TB-500, KPV and BPC-157 designed around research involving skin, inflammation and tissue repair.
A cosmetic signaling peptide, commonly identified as acetyl octapeptide-3, studied mainly in topical anti-wrinkle formulations.
A naturally occurring coenzyme involved in cellular energy production, redox metabolism and DNA-repair pathways.
A higher-strength NAD+ format centered on the same naturally occurring coenzyme involved in cellular energy, redox metabolism and DNA-repair pathways.
A long-acting amylin analogue being studied for appetite regulation, satiety and body-weight outcomes.
A small-molecule NNMT inhibitor studied preclinically for metabolic regulation. Despite its catalog grouping, it is not a peptide.
A commercial product promoted for fat reduction, but regulators have challenged injectable claims and product authorization.
A copper-binding tripeptide investigated in laboratory and ex-vivo research on dermal papilla cells and hair-follicle growth.
Glutathione is an endogenous antioxidant tripeptide, but injectable skin-lightening claims are not supported by approved clinical evidence.
A synthetic tetrapeptide studied in cellular aging and telomere biology, with clinical longevity claims remaining unproven.
A synthetic peptide investigated mainly in small Russian clinical studies for anxiety-related symptoms and neurocognitive effects.
A synthetic peptide investigated for neurological signaling, cognition and neuroprotective pathways.
Delta sleep-inducing peptide, an experimental neuropeptide with older and mixed human research on sleep.
A mitochondria-targeting tetrapeptide also known as elamipretide, studied in mitochondrial disease and cellular bioenergetics.
A melanocortin-receptor agonist related to bremelanotide, a prescription medicine with a narrowly defined HSDD indication.
A reproductive neuropeptide that activates the GnRH pathway and has been studied in human reproductive-endocrine research.
A polynucleotide-based skinbooster variant designed around PN with added hydration and local-anesthetic components in the Rejuran family.
A full-face polynucleotide skinbooster from the Rejuran family, positioned around skin-quality and tissue-repair applications.
A Rejuran polynucleotide variant designed for thinner, delicate treatment areas such as the periocular region.
A Rejuran polynucleotide variant intended for focused professional aesthetic use in areas such as scars and deeper textural concerns.
OnabotulinumtoxinA 100-unit professional-use product for specific approved cosmetic indications when genuine and appropriately licensed.
A botulinum toxin type A professional-use product whose approved indications and registration status vary by country.
A botulinum toxin type A professional-use product whose approved indications and registration status vary by market.
A commercial multi-component antioxidant infusion kit whose skin-lightening claims are not established by approved injectable evidence.
A botulinum toxin type A product intended for qualified professional use, with evidence and authorization that must be assessed product-specifically.
A commercial glutathione-based drip formulation whose exact composition and evidence should be verified from the current label and COA.
A glutathione-focused commercial injectable format that should be described from verified label data rather than cosmetic whitening claims.
A human placental extract prescription product with a specific medical indication in Japan, not an established general beauty or anti-aging injectable.
A tranexamic-acid product. TXA has clinical research in melasma, but route, dose and product-specific safety cannot be generalized.
A multi-ingredient commercial infusion kit whose cosmetic claims should not exceed the evidence for its verified individual ingredients.
An injection-lipolysis product marketed for localized fat reduction, but not an FDA-approved fat-dissolving injectable in the United States.
A commercial injection-lipolysis product for which robust product-specific efficacy and safety evidence has not been verified.
A commercial fat-dissolving injection format whose evidence depends on its verified ingredients, formulation and market authorization.
A commercial injection-lipolysis format with limited verified product-specific clinical evidence.